Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dieter Naber

Showing results (1-10 of 150) with videos related to

Pageof 15
Sort By:
Expert Opinion on Pharmacotherapy|January 25, 2011
Olanzapine pamoate for the treatment of schizophreniaDieter Naber
Epidemiologia E Psichiatria Sociale|October 18, 2008
Subjective effects of antipsychotic drugs and their relevance for compliance and remissionDieter Naber
Acta Psychiatrica Scandinavica|January 26, 2005
Subjective effects of antipsychotic treatmentDieter Naber
Dialogues in Clinical Neuroscience|January 28, 2009
Dialogues in clinical neuroscience. Remission in depressionDieter Naber
CNS Drugs|October 6, 2004
Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of lifeMartin Lambert, Dieter Naber
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 2, 2004
Tools for measuring clinical effectivenessDieter Naber, Antonio Vita
Psychiatrische Praxis|April 27, 2005
[Pro and contra: basic precedence of atypical neuroleptics]Dieter Naber, Matthias Dose
Expert Review of Neurotherapeutics|October 9, 2009
Atypical antipsychotics in the treatment of schizophrenic patientsChristian Otte, Dieter Naber
Dialogues in Clinical Neuroscience|June 28, 2018
Psychiatric sequelae of cardiac arrestDieter Naber, Monika Bullinger
Current Opinion in Psychiatry|April 28, 2006
Hand-offs and trade-offs in psychiatric careDieter Naber, Harold Pincus
Pageof 15

Showing results (1-10 of 150) with videos related to

Sort By:
Pageof 15
Expert Opinion on Pharmacotherapy|January 25, 2011
Olanzapine pamoate for the treatment of schizophreniaDieter Naber
Epidemiologia E Psichiatria Sociale|October 18, 2008
Subjective effects of antipsychotic drugs and their relevance for compliance and remissionDieter Naber
Acta Psychiatrica Scandinavica|January 26, 2005
Subjective effects of antipsychotic treatmentDieter Naber
Dialogues in Clinical Neuroscience|January 28, 2009
Dialogues in clinical neuroscience. Remission in depressionDieter Naber
CNS Drugs|October 6, 2004
Current issues in schizophrenia: overview of patient acceptability, functioning capacity and quality of lifeMartin Lambert, Dieter Naber
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 2, 2004
Tools for measuring clinical effectivenessDieter Naber, Antonio Vita
Psychiatrische Praxis|April 27, 2005
[Pro and contra: basic precedence of atypical neuroleptics]Dieter Naber, Matthias Dose
Expert Review of Neurotherapeutics|October 9, 2009
Atypical antipsychotics in the treatment of schizophrenic patientsChristian Otte, Dieter Naber
Dialogues in Clinical Neuroscience|June 28, 2018
Psychiatric sequelae of cardiac arrestDieter Naber, Monika Bullinger
Current Opinion in Psychiatry|April 28, 2006
Hand-offs and trade-offs in psychiatric careDieter Naber, Harold Pincus
Pageof 15